New drug combo tested for Tough-to-Treat blood cancers
Disease control
Terminated
This early-phase study tested whether adding the drug rapamycin to a standard high-dose chemotherapy regimen (HiVAC) was safe and effective for adults with aggressive blood cancers that had returned or stopped responding to previous treatments. The goal was to see if this combina…
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC